Biogen Pharmachem Industries Ltd — Board Meeting, 23-07-2025: Board Meeting

Biogen Pharmachem Industries' board has approved the financial results for the quarter ended June 30, 2025. The company reported robust operational performance with revenue from operations at Rs 1.54 crore, a healthy increase from Rs 1.35 crore in the prior-year quarter. Net profit rose to Rs 1.34 crore compared to Rs 1.17 crore previously. However, basic earnings per share decreased to Rs 0.01 from Rs 0.02, attributed to a notable increase in the paid-up equity share capital. This highlights strong profit growth, but dilution impacted per-share metrics.